Supplemental Figure S5 from Requirement for Innate Immunity and CD90+ NK1.1− Lymphocytes to Treat Established Melanoma with Chemo-Immunotherapy
Year: 2023
Type: supplementary-materials
Abstract: Therapy with αTRP1+CY can activate T cells against melanoma.
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4362618532
